BNGO’s Debt-to-Equity Ratio at 0.43: What It Means for Bionano Genomics Inc’s Future

HCCC Stock

Bionano Genomics Inc (BNGO) has a current stock price of $4.13. During the previous trading session, the stock witnessed a notable rise, reaching a high of $11.0 after opening at $4.13. The stock’s low for the day was $8.0, and it eventually closed at $3.41.

Bionano Genomics Inc had a pretty Dodgy run when it comes to the market performance. Over the past year, the company’s stock reached a high of $33.72 on 08/22/24, while the lowest price during the same period was $2.68 on 04/07/25.

52-week price history of BNGO Stock

Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Bionano Genomics Inc’s current trading price is -87.75% away from its 52-week high, while its distance from the 52-week low is 54.10%. The stock’s price range for this period has remained between $2.68 and $33.72. The Healthcare sector company’s shares managed to surpass a trading volume of around 0.64 million for the day, which was noticeably higher compared to the shares’ average daily volume of 89610.0 over the last three months.

Financial Performance and Market Capitalization

Bionano Genomics Inc (BNGO) has experienced a quarterly rise of 14.09% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 19.33M and boasts a workforce of 100 employees.

Moving average and trading volume data

Based on Barchart.com data, the company’s moving average over the 100-day period was 3.55, with a change in price of +1.23. Similarly, Bionano Genomics Inc recorded 130,623 in trading volume during the last 100 days, posting a change of +42.41%.

BNGO Debt-to-equity ratio analysis

The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for BNGO stands at 0.43. Similarly, the long-term debt-to-equity ratio is also 0.14.

BNGO Stock Stochastic Average

As of today, the raw stochastic average of Bionano Genomics Inc over the last 50 days is at 92.38%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 92.38%. Further, the company’s Stochastic %K and %D values for the last 20 days were 76.96% and 58.41%, respectively.

BNGO Stock Price Performance Analysis

Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The index has shown a price loss of -87.64% this year. Over the last six months, there has been a stronger performance of -22.66%. The price of BNGO fallen by 18.00% during the last 30 days period. For the last 5-days stocks have improved 28.66%.

Most Popular

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.